JP2993767B2 - FO-1289A substance and method for producing the same - Google Patents
FO-1289A substance and method for producing the sameInfo
- Publication number
- JP2993767B2 JP2993767B2 JP3162183A JP16218391A JP2993767B2 JP 2993767 B2 JP2993767 B2 JP 2993767B2 JP 3162183 A JP3162183 A JP 3162183A JP 16218391 A JP16218391 A JP 16218391A JP 2993767 B2 JP2993767 B2 JP 2993767B2
- Authority
- JP
- Japan
- Prior art keywords
- substance
- culture
- producing
- aspergillus
- belonging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000126 substance Substances 0.000 title claims description 51
- PMMQOFWSZRQWEV-RVTXXDJVSA-N pyripyropene A Chemical compound O([C@]1(C)[C@@H](OC(C)=O)C[C@@H]2[C@]([C@H]1[C@@H](O)C=1C(=O)O3)(C)CC[C@@H]([C@@]2(C)COC(=O)C)OC(C)=O)C=1C=C3C1=CC=CN=C1 PMMQOFWSZRQWEV-RVTXXDJVSA-N 0.000 title claims description 29
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- 241000228212 Aspergillus Species 0.000 claims description 9
- 244000005700 microbiome Species 0.000 claims description 9
- 241000228257 Aspergillus sp. Species 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- 238000000862 absorption spectrum Methods 0.000 claims description 6
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- 230000007935 neutral effect Effects 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 3
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 238000001819 mass spectrum Methods 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 238000001228 spectrum Methods 0.000 claims description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 11
- 239000002609 medium Substances 0.000 description 11
- 102000001494 Sterol O-Acyltransferase Human genes 0.000 description 9
- 108010054082 Sterol O-acyltransferase Proteins 0.000 description 9
- 239000005516 coenzyme A Substances 0.000 description 9
- 229940093530 coenzyme a Drugs 0.000 description 9
- 239000000284 extract Substances 0.000 description 8
- 229920001817 Agar Polymers 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 7
- -1 acyl coenzyme A Chemical compound 0.000 description 7
- 239000008272 agar Substances 0.000 description 7
- 229940041514 candida albicans extract Drugs 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 7
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 7
- 239000012138 yeast extract Substances 0.000 description 7
- 235000012000 cholesterol Nutrition 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- 238000005273 aeration Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 150000001840 cholesterol esters Chemical class 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- NNJPGOLRFBJNIW-HNNXBMFYSA-N (-)-demecolcine Chemical compound C1=C(OC)C(=O)C=C2[C@@H](NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-HNNXBMFYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 230000018842 conidium formation Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 210000000497 foam cell Anatomy 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 210000001853 liver microsome Anatomy 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 102220201851 rs143406017 Human genes 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、アシルコエンザイムA
コレステロールアシル転位酵素阻害を有する新規物質F
O−1289A物質およびその製造法に関する。The present invention relates to an acyl coenzyme A
Novel substance F having cholesterol acyltransferase inhibition
The present invention relates to an O-1289A substance and a method for producing the same.
【0002】[0002]
【従来の技術】従来、いくつかの高脂血症薬物が知られ
ていたが、未だに有効な物質は得られていない。2. Description of the Related Art Conventionally, several hyperlipidemic drugs have been known, but no effective substance has been obtained yet.
【0003】[0003]
【発明が解決しようとする課題】近年、食生活の向上に
伴い成人の高脂血症や動脈硬化などコレステロール蓄積
に起因する症状が現代病として問題視されている。コレ
ステロールはアシルコエンザイムAからアシル基転位に
よりコレステロールエステルとなり、細胞内および血中
リポ蛋白に蓄積される。このアシル基転位反応を触媒す
る酵素がアシルコエンザイムAコレステロールアシル転
位酵素であり、コレステロールの腸管からの吸収および
冠動脈における泡沫細胞の形成に深く係わっている。し
たがって、アシルコエンザイムAコレステロールアシル
転位酵素を阻害する物質は、かかる疾病に有効であるこ
とが推察される。In recent years, symptoms caused by cholesterol accumulation such as hyperlipidemia and arteriosclerosis in adults have been regarded as a modern disease with the improvement of dietary habits. Cholesterol is converted into a cholesterol ester by acyl group transfer from acyl coenzyme A, and is accumulated in lipoproteins in cells and blood. The enzyme that catalyzes the acyl transfer reaction is acyl coenzyme A cholesterol acyl transferase, which is closely involved in the absorption of cholesterol from the intestinal tract and the formation of foam cells in coronary arteries. Therefore, it is presumed that a substance that inhibits acyl coenzyme A cholesterol acyltransferase is effective for such diseases.
【0004】かかる実情において、アシルコエンザイム
Aコレステロールアシル転位酵素阻害活性を有する物質
を提供することは、高脂血症やそれに基く動脈硬化など
の成人病の治療上有用なことである。Under such circumstances, it is useful to provide a substance having acylcoenzyme A cholesterol acyltransferase inhibitory activity in the treatment of adult diseases such as hyperlipidemia and arteriosclerosis.
【0005】[0005]
【課題を解決するための手段】本発明者らは、微生物の
生産する代謝産物に付いて研究を続けた結果、新たな土
壌から分離したFO−1289菌株の培養物中にアシル
コエンザイムAコレステロールアシル転位酵素阻害活性
を有する物質が産生されることを見出した。次いで、該
培養物からアシルコエンザイムAコレステロールアシル
転位酵素阻害活性物質を分離、精製した結果、後記の理
化学的性質を有する物質は従来全く知られていないこと
から、本物質をFO−1289A物質と称することにし
た。本発明は、係る知見に基いて完成されたものであっ
て、分子式C31H37NO10で表されるFO−1289A
物質を提供するものである。The present inventors have continued their research on metabolites produced by microorganisms and found that acyl coenzyme A cholesterol acyl was contained in a culture of FO-1289 strain isolated from fresh soil. It has been found that a substance having a translocation enzyme inhibitory activity is produced. Next, the substance having acylcoenzyme A cholesterol acyltransferase inhibitory activity was separated and purified from the culture, and as a result, no substance having the physicochemical properties described below has been known at all. Therefore, this substance is referred to as FO-1289A substance. It was to be. The present invention has been completed on the basis of the above findings, and is a FO-1289A represented by a molecular formula of C 31 H 37 NO 10.
To provide the substance.
【0006】更に、本発明は、アスペルギルス属に属
し、FO−1289A物質を生産する能力を有する微生
物を培地に培養して培養物にFO−1289A物質を蓄
積せしめ、該培養物からFO−1289A物質を採取す
ることを特徴とするFO−1289A物質の製造法を提
供するものである。Further, the present invention relates to a method of culturing a microorganism belonging to the genus Aspergillus and having the ability to produce a FO-1289A substance in a culture medium to accumulate the FO-1289A substance in a culture, and then producing the FO-1289A substance from the culture. And a method for producing a FO-1289A substance.
【0007】FO−1289A物質を生産する能力を有
する微生物(以下、FO−1289A物質生産菌と称す
る)は、アスペルギルス属に属するが、例えば本発明者
らが分離したアスペルギルス属に属するFO−1289
菌株は、本発明の最も有効に使用される菌株の一例であ
って、本菌株の菌学的性状を示すと次の通りである。[0007] Microorganisms capable of producing the FO-1289A substance (hereinafter referred to as FO-1289A substance-producing bacteria) belong to the genus Aspergillus, and for example, FO-1289 belonging to the genus Aspergillus isolated by the present inventors.
The strain is an example of the most effectively used strain of the present invention, and the microbiological properties of the strain are as follows.
【0008】本発明のFO−1289A物質を生産する
ために使用される菌株としては、例えば本発明者らによ
つて土壌から分離されたアスペルギルス エスピー.
(Aspergillus sp.)FO−1289株
が挙げられる。The strain used for producing the FO-1289A substance of the present invention includes, for example, Aspergillus sp. Isolated from the soil by the present inventors.
( Aspergillus sp.) FO-1289 strain.
【0009】I.本菌株は、マルトエキストラクト寒天
培地、ツアペツク・イーストエキストラクト寒天培地、
20%シユークロース・ツアペツク・イーストエキスト
ラクト寒天培地で良好に生育し、分生子の着生も良好で
ある。ツアペツク・イーストエキストラクト寒天培地に
生育したコロニーを顕微鏡で観察すると、菌糸は透明で
隔壁を有しており、分生子柄は主に基底菌糸より直生
し、その表面は滑面である。I. This strain is a malt extract agar medium, Tupetsk yeast extract agar medium,
It grows well on a 20% sucrose-tupetsk-yeast extract agar medium and has good conidium formation. When the colonies grown on the Tupetsk yeast extract agar medium are observed with a microscope, the hyphae are transparent and have partition walls, the conidiophores mainly grow straight from the basal hyphae, and the surface is smooth.
【0010】分生子柄の先端は、ふくらみ、フラスコ形
の頂のう(直径10−25μm)を形成する。メトレは
形成されず、フイアライドは頂のう上に直生する。分生
子は直径2〜3μmで、その形は球形、亜球形である。The tips of the conidiophores bulge, forming a flask-shaped apex (10-25 μm in diameter). No metres are formed, and the fluoride grows directly on the top. Conidia are 2-3 μm in diameter and are spherical and subspherical.
【0011】II.培養上の諸性状 (1)表1に本菌株の培養所見を示す。本所見は各種培
地上で25℃、7日間培養した場合の肉眼的に観察した
結果である。II. Characteristics of culture (1) Table 1 shows the culture findings of this strain. This finding is the result of macroscopic observation when cultured on various media at 25 ° C. for 7 days.
【0012】[0012]
【表1】 [Table 1]
【0013】(2)ツアペツク・イーストエキストラク
ト寒天培地における37℃、7日間培養した場合の生育
状態は、非常に旺盛(80mm以上)である。一方、5
℃、7日間培養した場合、生育しなかった。前記のすべ
ての培地には、菌の生育に伴う分泌液および菌核の形成
は観察されなかった。(2) The growth state when cultured at 37 ° C. for 7 days on a Tupetsk yeast extract agar medium is very vigorous (80 mm or more). 5
When the cells were cultured at 7 ° C. for 7 days, they did not grow. No formation of secretions and sclerotium was observed in all of the above-mentioned media as the bacteria grew.
【0014】III.生理学的性状 (1)生育温度範囲:15℃〜47℃、至適生育温度範
囲27℃〜40℃ (2)生育pH範囲:3〜11、至適生育pH範囲5〜
8 (3)好気性、嫌気性の区別:好気性III. Physiological properties (1) Growth temperature range: 15 ° C to 47 ° C, optimal growth temperature range 27 ° C to 40 ° C (2) Growth pH range: 3 to 11, optimal growth pH range 5 to 5
8 (3) Aerobic and anaerobic distinction: aerobic
【0015】上記FO−1289株の形態的特徴、培養
上の諸性状、生理学的性状に基づき、既知菌種との比較
を試みた結果、本菌株をアスペルギルス(Asperg
illus)属に属する一菌株と同定し、アスペルギル
ス エスピー.FO−1289と命名した。本菌株は、
アスペルギルス エスピー.FO−1289(Aspe
rgillus sp.FO−1289)として工業技
術院微生物工業技術研究所に寄託されている。(FER
M P−12194号)。[0015] Based on the morphological characteristics, culture characteristics, and physiological characteristics of the FO-1289 strain, an attempt was made to compare it with known bacterial strains. As a result, this strain was identified as Aspergillus ( Asperg).
illus ), identified as one strain belonging to the genus Aspergillus sp. FO-1289. This strain is
Aspergillus sp. FO-1289 ( Aspe
rgillus sp. FO-1289). (FER
MP-12194).
【0016】以上、FO−1289A生産菌について説
明したが、菌の一般的性状として菌学上の性状はきわめ
て変異し易く、一定したものではなく、自然的にあるい
は通常行われる紫外線照射または変異誘導体、例えばN
−メチル−N−ニトロ−N−ニトロソグアニジン、エチ
ルメタンスルホネートなどを用いる人工的変異手段によ
り変異することは周知の事実であり、このような人工的
変異株は勿論、自然変異株も含め、アスペルギルス属に
属し、FO−1289A物質を生産する能力を有する菌
株は、すべて本発明に使用することができる。また、細
胞融合、遺伝子操作などの細胞工学的に変異させた菌株
も物質FO−1289A物質生産菌として包含される。The FO-1289A producing bacteria have been described above. However, as a general property of the bacteria, the mycological properties are extremely liable to vary, are not constant, and are naturally or normally performed by ultraviolet irradiation or mutated derivatives. , For example N
-Methyl-N-nitro-N-nitrosoguanidine, ethyl methanesulfonate, etc., it is a well-known fact that mutation occurs by artificial mutation means. Any strain belonging to the genus and capable of producing the FO-1289A substance can be used in the present invention. In addition, strains mutated by cell engineering such as cell fusion and genetic manipulation are also included as substance FO-1289A substance-producing bacteria.
【0017】本発明においては、先ずアスペルギルス属
に属するFO−1289A物質生産菌が培地に培養され
る。本菌の培養においては、通常真菌の培養法が一般に
用いられる。培地としては、微生物が同化し得る炭素
源、資化し得る窒素源、さらには必要に応じて無機酸塩
などを含有させた栄養培地が使用される。同化し得る炭
素源としては、ブドウ糖、ショ糖、糖密、デキストリ
ン、セルロースなどが単独または組み合わせて用いられ
れる。In the present invention, a FO-1289A substance-producing bacterium belonging to the genus Aspergillus is first cultured in a medium. In culturing the fungus, a fungal culture method is generally used. As the medium, a nutrient medium containing a carbon source that can be assimilated by microorganisms, a nitrogen source that can be assimilated, and, if necessary, an inorganic acid salt or the like is used. As the assimilable carbon source, glucose, sucrose, molasses, dextrin, cellulose and the like are used alone or in combination.
【0018】資化し得る窒素源としては、ペプトン、肉
エキス、酵母エキス、乾燥酵母、大豆粉、コーン・ステ
イープ・リカー、綿実粕、カゼイン、大豆蛋白加水分解
物、アミノ酸、尿素などの有機窒素源、硝酸塩、アンモ
ニウム塩などの無機窒素化合物が単独または組み合わせ
て用いられる。その他、必要に応じてナトリウム塩、カ
リウム塩、カルシウム塩、マグネシウム塩、リン酸塩な
どの無機塩、重金属塩類が添加される。さらに、培地に
は、必要に応じて、本菌の生育やFO−1289A物質
の生産を促進する微量栄養素、発育促進物質、前駆物質
などを適当に添加してもよい。Examples of nitrogen sources that can be assimilated include organic nitrogen such as peptone, meat extract, yeast extract, dried yeast, soy flour, corn steep liquor, cottonseed meal, casein, soybean protein hydrolyzate, amino acids, and urea. Sources, inorganic nitrogen compounds such as nitrates and ammonium salts are used alone or in combination. In addition, if necessary, inorganic salts such as sodium salt, potassium salt, calcium salt, magnesium salt and phosphate, and heavy metal salts are added. Furthermore, if necessary, micronutrients, growth promoting substances, precursors, and the like that promote the growth of the present bacterium and the production of the FO-1289A substance may be appropriately added to the medium.
【0019】培養は通常振とうまたは通気攪拌培養など
の好気的条件下で行うのがよい。工業的には深部通気攪
拌培養が好ましい。培養のpHは中性付近で培養を行う
のが好ましい。培養温度は20〜37℃で行い得るが、
通常は24〜30℃に保つのがよい。培養時間は、液体
の場合、通常2〜3日間培養を行うと、本FO−128
9A物質が蓄積されるので、培養中の蓄積量が最大に達
した時に、培養を終了すればよい。The culture is usually carried out under aerobic conditions such as shaking or aeration and stirring culture. Industrially, deep aeration stirring culture is preferred. The culture is preferably performed at a pH around neutrality. The cultivation temperature can be 20-37 ° C,
Usually, it is good to keep at 24 to 30 ° C. In the case of liquid, the FO-128 is usually cultured for 2 to 3 days.
Since the substance 9A is accumulated, the culture may be terminated when the accumulated amount during the culture reaches the maximum.
【0020】これらの培地組成、培地の液性、培養温
度、培養速度、通気量などの培養条件は使用する菌株の
種類や外部の条件などに応じて好ましい結果が得られる
ように適宜調節、選択されることはいうまでもない。液
体培養において、発泡があるときは、シリコン油、植物
油、界面活性剤などの消泡剤を適宜使用できる。The culture conditions such as the medium composition, the liquid properties of the medium, the culture temperature, the culture rate and the aeration rate are appropriately adjusted and selected so as to obtain preferable results according to the kind of the strain used and the external conditions. Needless to say. If there is foaming in the liquid culture, an antifoaming agent such as silicone oil, vegetable oil, or a surfactant can be used as appropriate.
【0021】このようにして得られた培養物に蓄積され
るFO−1289A物質は、菌体内および培養濾液中に
含有されるので、培養物を遠心分離して培養濾液と菌体
とに分離し、各々から本FO−1289A物質を採取す
るのが有利である。Since the FO-1289A substance accumulated in the culture thus obtained is contained in the cells and in the culture filtrate, the culture is centrifuged to separate the culture filtrate and the cells. , It is advantageous to collect the present FO-1289A material from each.
【0022】培養濾液からFO−1289A物質を採取
するには、先ず培養濾液を酢酸エチル、酢酸ブチル、ベ
ンゼンなどの非親水性有機溶媒で抽出し、抽出液を減圧
濃縮して粗製のFO−1289A物質が得られる。この
粗製物質はさらに脂溶性物質の精製に通常用いられる公
知の方法、例えばシリカゲル、アルミナなどの担体を用
いるカラムクロマトグラフイーにより各々FO−128
9A物質を分離精製することができる。To collect the FO-1289A substance from the culture filtrate, the culture filtrate is first extracted with a non-hydrophilic organic solvent such as ethyl acetate, butyl acetate, benzene, etc., and the extract is concentrated under reduced pressure to obtain crude FO-1289A. The substance is obtained. The crude substance is further purified by a known method usually used for purification of a fat-soluble substance, for example, FO-128 by column chromatography using a carrier such as silica gel or alumina.
9A substance can be separated and purified.
【0023】菌体からFO−1289A物質を採取する
には、菌体を含水アセトン、含水メタノールなどの含水
親水性有機溶媒で抽出し、得られた抽出液を減圧濃縮
し、その濃縮物を酢酸エチル、酢酸ブチル、ベンゼンな
どの非親水性有機溶媒で抽出し、得られた抽出液は、前
記の培養濾液から得た抽出液と合わせて分離精製する
か、あるいは前記同じ方法によりFO−1289A物質
を分離精製することができる。To collect the FO-1289A substance from the cells, the cells are extracted with a water-containing hydrophilic organic solvent such as water-containing acetone and water-containing methanol, and the obtained extract is concentrated under reduced pressure. The extract is extracted with a non-hydrophilic organic solvent such as ethyl, butyl acetate, benzene, etc., and the obtained extract is separated and purified in combination with the extract obtained from the culture filtrate, or the FO-1289A substance is obtained by the same method as described above. Can be separated and purified.
【0024】次に、本発明のF−1289A物質の理化
学的性状について述べる。 (1)分子式;C31H37NO10(高分解能スペクトルで
m/z583が観察された) (2)分子量;583(マススペクトルよりm/z58
3(M+ )が観察された) (3)比旋光度;〔α〕22 D =+73.2(C=1、ク
ロロホルム) (4)紫外線吸収スペクトル(メタノール中);図1の
通り (5)赤外線吸収スペクトル(四塩化炭素中);図2の
通りNext, the physicochemical properties of the substance F-1289A of the present invention will be described. (1) molecular formula; C 31 H 37 NO 10 (m / z 583 was observed in the high-resolution spectrum) (2) molecular weight; 583 (m / z 58 from the mass spectrum)
((3) (M + ) was observed) (3) Specific rotation; [α] 22 D = +73.2 (C = 1, chloroform) (4) Ultraviolet absorption spectrum (in methanol); ) Infrared absorption spectrum (in carbon tetrachloride);
【0025】(6)溶媒に対する溶解性;メタノール、
エタノール、アセトニトリル、酢酸エチル、ベンゼンに
可溶、水に不溶 (7)塩基性、酸性、中性の区別;中性 (8)物質の色、形状;黄色粉末 (9)プロトン核磁気共鳴スペクトル(重クロロホルム
中);図3の通り。(6) Solubility in a solvent: methanol,
Soluble in ethanol, acetonitrile, ethyl acetate, benzene, insoluble in water (7) Distinguishing between basic, acidic and neutral; neutral (8) Color and shape of substance; yellow powder (9) Proton nuclear magnetic resonance spectrum ( In deuterated chloroform); as in FIG.
【0026】次に、本発明のFO−1289A物質の生
物学的性状について述べる。 (1)ラツト由来アシルコエンザイムAコレステロール
アシル転位酵素に対する阻害作用 アシルコエンザイムAコレステロールアシル転位酵素活
性に対する影響はラツト肝ミクロソーム画分より調整し
た粗酵素を用い300μM〔1−14C〕Oleoyl−
CoA;3mg/mlコレステロールを各々20μl (0.
02μCi);6.67μl 添加し、37℃で30分間
反応させ、総脂質をクロロホルム:メタノール(2:
1)混合液で抽出後、TLC(キーゼルゲルGF254 、
展開溶媒として石油エーテル:ジエチルエーテル:酢
酸、90:10:1)で各脂質を分離後、コレステロー
ルエステル画分をかきとり、液体シンチレーシヨンカウ
ンターでアシルコエンザイムAコレステロールアシル転
位酵素活性を測定した。本酵素活性を50%阻害する濃
度を算定した結果はFO−1289A物質で0.03μ
g/mlであつた。Next, the biological properties of the FO-1289A substance of the present invention will be described. (1) rats from acyl-coenzyme A influence on the inhibitory action acyl-coenzyme A cholesterol acyltransferase activity against cholesterol acyltransferase is used crude enzyme prepared from rat liver microsome fraction 300μM [1-14 C] Oleoyl-
CoA; 20 μl each of 3 mg / ml cholesterol (0.
02 μCi); 6.67 μl was added thereto, and reacted at 37 ° C. for 30 minutes.
1) After extraction with the mixture, TLC (Kieselgel GF 254 ,
After separating each lipid with petroleum ether: diethyl ether: acetic acid (90: 10: 1) as a developing solvent, the cholesterol ester fraction was scraped off, and acyl coenzyme A cholesterol acyltransferase activity was measured with a liquid scintillation counter. The result of calculating the concentration that inhibits the enzyme activity by 50% is 0.03 μm for the FO-1289A substance.
g / ml.
【0027】[0027]
【発明の効果】以上のように、本発明のFO−1289
A物質は、アシルコエンザイムAコレステロールアシル
転位酵素に対して著しい阻害活性を示すことから、ヒト
のコレステロール蓄積に起因する疾病の予防および治療
に有用である。As described above, the FO-1289 of the present invention has been described.
Substance A exhibits a remarkable inhibitory activity on acyl coenzyme A cholesterol acyltransferase and is therefore useful for prevention and treatment of diseases caused by cholesterol accumulation in humans.
【0028】次に、実施例を挙げて本発明を具体的に説
明する。Next, the present invention will be described specifically with reference to examples.
【実施例】500ml容三角フラスコにグルコース0.1
%、スターチ2.4%、ペプトン0.3%、肉エキス
0.3%、イーストエキストラクト0.5%、炭酸カル
シウム0.4%を含む培地(pH7.0に調整)100
mlを仕込み、綿栓後、蒸気滅菌し、寒天培地上に生育さ
せたアスペルギルス エスピー.FO−1289(FE
RM P−12194)を白金耳にて無菌的に接種し、
27℃で48時間振とう培養して種培養液を得た。[Example] 0.1 g of glucose was placed in a 500 ml Erlenmeyer flask.
100%, starch 2.4%, peptone 0.3%, meat extract 0.3%, yeast extract 0.5%, calcium carbonate 0.4% (adjusted to pH 7.0) 100
ml of Aspergillus sp., which had been cotton-plugged, steam-sterilized, and grown on an agar medium. FO-1289 (FE
RM P-12194) aseptically with a platinum loop.
A seed culture was obtained by shaking culture at 27 ° C. for 48 hours.
【0029】一方、50l ジヤーフアーメンター1基に
グルコース1.0%、トリプトン0.5%、酵母エキス
0.3%、マルトエキス0.3%、寒天0.1%(pH
6.0に調整)に仕込み、蒸気滅菌冷却後、種培養した
種培養液200mlを無菌的に移植し、攪拌速度250r
pm、通気量10l /分の培養条件下で27℃で72時
間、通気攪拌した。On the other hand, one 50 l jar armamenter contains 1.0% glucose, 0.5% tryptone, 0.3% yeast extract, 0.3% malt extract, 0.1% agar (pH
6.0), steam-sterilized and cooled, and then aseptically transplanted with 200 ml of a seed culture solution subjected to seed culture, and stirred at 250 rpm.
The mixture was stirred under aeration at 27 ° C. for 72 hours under culture conditions of 10 pm / min.
【0030】培養後、培養液30l を酢酸エチル18l
で抽出し、抽出液を減圧濃縮して粗製物を得た。この粗
製物をシリカゲル(250g、メルク社製、Art.9
385)のカラムにチヤージし、クロロホルム−メタノ
ール(99:1)で溶出するカラムクロマトグラフイー
を行った。各フラクシヨンは100mlづつ分画し、活性
成分を含むフラクシヨンを集め、減圧乾固して粗活性物
質1.5gを得た。After the cultivation, 30 l of the culture was added to 18 l of ethyl acetate.
And the extract was concentrated under reduced pressure to obtain a crude product. This crude product was silica gel (250 g, Merck, Art. 9).
385), and column chromatography was performed, eluting with chloroform-methanol (99: 1). Each fraction was fractionated in 100 ml portions, and the fractions containing the active ingredient were collected and dried under reduced pressure to obtain 1.5 g of a crude active substance.
【0031】これを5回に分けて高速液体クロマトグラ
フイーにより分離精製した。装置はトリロータV(日本
分光社製)を用い、カラムはYMC−Pack A−3
43(ODS系樹脂、山村化学研究所製)を用い、溶媒
系は、55%のアセトニトリル水を用い、検出はUV2
80nm、流速は8ml/分で行った。その結果、FO−
1289A物質50mgを単離した。This was separated and purified by high-performance liquid chromatography in five times. The device used was Trirotor V (manufactured by JASCO Corporation), and the column was YMC-Pack A-3.
43 (ODS resin, manufactured by Yamamura Chemical Laboratory), the solvent system was 55% acetonitrile water, and the detection was UV2.
At 80 nm, the flow rate was 8 ml / min. As a result, FO-
50 mg of 1289A substance was isolated.
【図1】FO−1289A物質の紫外線吸収スペクトル
である。(メタノール溶液として測定)FIG. 1 is an ultraviolet absorption spectrum of a FO-1289A substance. (Measured as methanol solution)
【図2】FO−1289A物質の赤外線吸収スペクトル
である。(四塩化炭素溶液として測定)FIG. 2 is an infrared absorption spectrum of a FO-1289A substance. (Measured as carbon tetrachloride solution)
【図3】FO−1289A物質のプロトン核磁気共鳴ス
ペクトルである。(重クロロホルム溶液として測定)FIG. 3 is a proton nuclear magnetic resonance spectrum of the FO-1289A substance. (Measured as deuterated chloroform solution)
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI C12R 1:66) (58)調査した分野(Int.Cl.6,DB名) C07G 17/00 C12N 1/14 C12P 1/02 BIOSIS(DIALOG) WPI(DIALOG)──────────────────────────────────────────────────続 き Continuation of the front page (51) Int.Cl. 6 identification code FI C12R 1:66) (58) Investigated field (Int.Cl. 6 , DB name) C07G 17/00 C12N 1/14 C12P 1 / 02 BIOSIS (DIALOG) WPI (DIALOG)
Claims (5)
9A物質。 (1)分子式;C31H37NO10(高分解能スペクトルで
m/z583が観察された) (2)分子量;583(マススペクトルよりm/z58
3(M+ )が観察された) (3)比旋光度;〔α〕22 D =+73.2(C=1、ク
ロロホルム) (4)紫外線吸収スペクトル(メタノール中);図1の
通り (5)赤外線吸収スペクトル(四塩化炭素中);図2の
通り (6)溶媒に対する溶解性;メタノール、エタノール、
アセトニトリル、酢酸エチル、ベンゼンに可溶、水に不
溶 (7)塩基性、酸性、中性の区別;中性 (8)物質の色、形状;黄色粉末1. FO-128 having the following physicochemical properties:
9A substance. (1) molecular formula; C 31 H 37 NO 10 (m / z 583 was observed in the high-resolution spectrum) (2) molecular weight; 583 (m / z 58 from the mass spectrum)
((3) (M + ) was observed) (3) Specific rotation; [α] 22 D = +73.2 (C = 1, chloroform) (4) Ultraviolet absorption spectrum (in methanol); ) Infrared absorption spectrum (in carbon tetrachloride); as shown in FIG. 2 (6) Solubility in solvent; methanol, ethanol,
Soluble in acetonitrile, ethyl acetate, benzene, insoluble in water (7) Basic, acidic, neutral distinction; neutral (8) Color and shape of substance; yellow powder
9A物質を生産する能力を有する微生物を培地に培養し
て培養中にFO−1289A物質を蓄積せしめ、該培養
物からFO−1289A物質を採取することを特徴とす
るFO−1289A物質の製造法。2. FO-128 belonging to the genus Aspergillus
A method for producing a FO-1289A substance, comprising culturing a microorganism capable of producing a 9A substance in a medium, accumulating the FO-1289A substance in the culture, and collecting the FO-1289A substance from the culture.
9A物質を生産する能力を有する微生物がアスペルギル
ス エスピー.FO−1289(Aspergillu
s sp.FO−1289 FERM P−1219
4)である請求項2記載の製造法。3. FO-128 belonging to the genus Aspergillus
A microorganism capable of producing the 9A substance is Aspergillus sp. FO-1289 ( Aspergillu)
s sp. FO-1289 FERM P-1219
3. The method according to claim 2, wherein the method is 4).
9A物質を生産する能力を有する微生物。4. FO-128 belonging to the genus Aspergillus
A microorganism capable of producing 9A substances.
O−1289である請求項4記載の微生物。5. The method according to claim 5, wherein the microorganism is Aspergillus sp. F
The microorganism according to claim 4, which is O-1289.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3162183A JP2993767B2 (en) | 1991-06-06 | 1991-06-06 | FO-1289A substance and method for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3162183A JP2993767B2 (en) | 1991-06-06 | 1991-06-06 | FO-1289A substance and method for producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH04360895A JPH04360895A (en) | 1992-12-14 |
| JP2993767B2 true JP2993767B2 (en) | 1999-12-27 |
Family
ID=15749591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3162183A Expired - Lifetime JP2993767B2 (en) | 1991-06-06 | 1991-06-06 | FO-1289A substance and method for producing the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2993767B2 (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006129714A1 (en) | 2005-06-01 | 2006-12-07 | Meiji Seika Kaisha, Ltd. | Pest control agent |
| WO2008108491A1 (en) | 2007-03-08 | 2008-09-12 | Meiji Seika Kaisha, Ltd. | Pest control composition |
| WO2009081851A1 (en) | 2007-12-21 | 2009-07-02 | Meiji Seika Kaisha, Ltd. | Novel systemic pesticide |
| WO2012035010A1 (en) | 2010-09-14 | 2012-03-22 | Basf Se | Composition containing a pyripyropene insecticide and a base |
| WO2012035015A2 (en) | 2010-09-14 | 2012-03-22 | Basf Se | Composition containing a pyripyropene insecticide and an adjuvant |
| US9596843B2 (en) | 2012-03-12 | 2017-03-21 | Basf Se | Liquid concentrate formulation containing a pyripyropene insecticide I |
| US9861104B2 (en) | 2012-03-12 | 2018-01-09 | Basf Se | Method for producing an aqueous suspension concentrate formulation of a pyripyropene insecticide |
| US9924712B2 (en) | 2012-03-12 | 2018-03-27 | Basf Se | Liquid concentrate formulation containing a pyripyropene insecticide II |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3233476B2 (en) * | 1992-10-22 | 2001-11-26 | 社団法人北里研究所 | FO-1289 substance and method for producing the same |
| US7491738B2 (en) | 2005-06-01 | 2009-02-17 | Meiji Seika Kaisha, Ltd. | Pest control agents |
| ATE539080T1 (en) | 2006-11-30 | 2012-01-15 | Meiji Seika Pharma Co Ltd | PEST CONTROLS |
| MX2011000023A (en) | 2008-07-24 | 2011-03-30 | Meiji Seika Kaisha | Pyripyropene a biosynthetic gene. |
| DK2530164T3 (en) | 2010-01-26 | 2017-10-16 | Meiji Seika Pharma Co Ltd | Process for producing a pyripyropene. |
| TWI633185B (en) | 2010-01-26 | 2018-08-21 | 明治製果藥業股份有限公司 | Bilipiopene biosynthetic gene groups and nucleic acid constructs containing marker genes |
| US20120330022A1 (en) | 2010-01-26 | 2012-12-27 | Kentaro Yamamoto | Method for producing pyripyropene derivatives by the enzymatic method |
| EP2578084A4 (en) | 2010-05-24 | 2014-04-23 | Meiji Seika Pharma Co Ltd | AGENT TO FIGHT HARMFUL ORGANISMS |
| KR102139237B1 (en) | 2013-03-28 | 2020-07-29 | 바스프 에스이 | Production of pyripyropenes from dry biomass |
-
1991
- 1991-06-06 JP JP3162183A patent/JP2993767B2/en not_active Expired - Lifetime
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006129714A1 (en) | 2005-06-01 | 2006-12-07 | Meiji Seika Kaisha, Ltd. | Pest control agent |
| EP2111756A1 (en) | 2005-06-01 | 2009-10-28 | Meiji Seika Kaisha Ltd. | Pest control agents |
| WO2008108491A1 (en) | 2007-03-08 | 2008-09-12 | Meiji Seika Kaisha, Ltd. | Pest control composition |
| US9675075B2 (en) | 2007-03-08 | 2017-06-13 | Basf Se | Pest control composition |
| WO2009081851A1 (en) | 2007-12-21 | 2009-07-02 | Meiji Seika Kaisha, Ltd. | Novel systemic pesticide |
| WO2012035010A1 (en) | 2010-09-14 | 2012-03-22 | Basf Se | Composition containing a pyripyropene insecticide and a base |
| WO2012035015A2 (en) | 2010-09-14 | 2012-03-22 | Basf Se | Composition containing a pyripyropene insecticide and an adjuvant |
| US9723834B2 (en) | 2010-09-14 | 2017-08-08 | Basf Se | Composition containing a pyripyropene insecticide and a base |
| US9888689B2 (en) | 2010-09-14 | 2018-02-13 | Basf Se | Compositions containing a pyripyropene insecticide and an adjuvant |
| US9596843B2 (en) | 2012-03-12 | 2017-03-21 | Basf Se | Liquid concentrate formulation containing a pyripyropene insecticide I |
| US9861104B2 (en) | 2012-03-12 | 2018-01-09 | Basf Se | Method for producing an aqueous suspension concentrate formulation of a pyripyropene insecticide |
| US9924712B2 (en) | 2012-03-12 | 2018-03-27 | Basf Se | Liquid concentrate formulation containing a pyripyropene insecticide II |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH04360895A (en) | 1992-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3233476B2 (en) | FO-1289 substance and method for producing the same | |
| JP2993767B2 (en) | FO-1289A substance and method for producing the same | |
| WO2000058491A1 (en) | Novel substances kf-1040t4a, kf-1040t4b, kf-1040t5a and kf-1040t5b and process for producing the same | |
| JPH10287662A (en) | Fo-5637a and b substance, and their production | |
| KR100366258B1 (en) | Novel substances kf-1040 and process for producing the same | |
| JPH08239385A (en) | Fo-1289 substance and its production | |
| JP2710834B2 (en) | FO-608A substance and method for producing the same | |
| JP4351395B2 (en) | WK-5344A substance, WK-5344B substance and methods for producing them | |
| JP3074038B2 (en) | FO-1513A substance and method for producing the same | |
| JP2872311B2 (en) | FO-608B, C substance and method for producing the same | |
| JP4160149B2 (en) | Novel FO-6969 substance and process for producing the same | |
| JP3434860B2 (en) | FO-2546 substance and method for producing the same | |
| JPWO2000053792A1 (en) | WK-5344A substance and WK-5344B substance and their production method | |
| JP4380913B2 (en) | Novel FT-0554 substance and production method thereof | |
| JPH07242636A (en) | Fo-3216 substance and its production | |
| JPH0856688A (en) | Substance fo-2546 and its production | |
| EP0952227B1 (en) | A bio-resolution process | |
| JP2002275194A (en) | New FO-6979-M0 substance, FO-6979-M1 substance, FO-6979-M2 substance, FO-6979-M3 substance and FO-6979-M4 substance and their production methods | |
| JP2844214B2 (en) | Method for producing 4a-hydroxymilbemycin αs | |
| JP3580875B2 (en) | FO-4259 substance and method for producing the same | |
| JPS6250473B2 (en) | ||
| JPH03227971A (en) | Carbazole compound | |
| JPH08176157A (en) | Novel bioactive substance epostatin, method for producing the same and use thereof | |
| JPS62205055A (en) | Novel physiologically active substance sk-1894 and production thereof | |
| JPS644516B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071022 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081022 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081022 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091022 Year of fee payment: 10 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091022 Year of fee payment: 10 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101022 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101022 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111022 Year of fee payment: 12 |
|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111022 Year of fee payment: 12 |